Heart Failure Mortality Declining in Sweden: New Study Offers Hope
A new study from Karolinska Institutet brings encouraging news for heart failure patients in Sweden. Research published in the European Journal of Heart Failure reveals a significant decrease in heart failure mortality over the past two decades.
Improved Treatments Driving Change
Despite the positive trend, the prognosis for heart failure patients remains a concern. A staggering 25% of those diagnosed in 2022 died within a year. However, the study suggests that advancements in heart failure treatment are directly contributing to this decrease in mortality both at a population level and for individual patients.
“Our results highlight the effectiveness of current heart failure treatments and encourage continued implementation, even though these treatments are still underutilized,” says senior author Gianluigi Savarese, Associate Professor of Cardiology at Karolinska Institutet. “This finding also emphasizes the importance of developing new treatments to further improve outcomes for patients.”
Uneven Progress in Treatment Response
The study found that improvements were more pronounced in patients with heart failure with reduced left ventricular function. This group has benefited from several life-prolonging treatments developed in recent years. In contrast, patients with heart failure and preserved left ventricular function, for whom evidence-based treatment options are limited, saw slower progress.
“These findings underscore the urgent need for research into new treatments specifically for patients with heart failure and preserved left ventricular function, who represent approximately half of the heart failure population,” explains Felix Lindberg, postdoctoral fellow at Karolinska Institutet and the study’s first author.
Looking Ahead: Personalized Treatment Strategies
Despite the challenges, the study offers hope for the future. “This study also provides encouragement that recent advancements in heart failure treatment can continue to improve the quality of life and survival of heart failure patients in Sweden,” adds Lindberg.
The research team plans to utilize the Swedish Heart Failure Registry to proactively identify patients who require intensified treatment. This personalized approach aims to further reduce mortality and improve outcomes for individuals living with heart failure.
The study was funded by the Swedish Heart-Lung Foundation and has no reported conflicts of interest.
Learn More About Heart Failure
Heart failure is a serious condition, but with proper management and treatment, many individuals can live full and active lives. If you or someone you know is experiencing symptoms of heart failure, please consult a healthcare professional for diagnosis and treatment options.